US health authorities are calling for a pause in the use of the Johnson & Johnson vaccine after reports of extremely rare blood clotting cases started to surface. The Food and Drug Administration (FDA) reported six cases in 6.8 million doses administered. Johnson & Johnson also stated that it was delaying rollout in Europe.
The vaccine was approved in the US on 27 February but, with US government, which has the highest amount of COVID-19 cases worldwide, hoping to administer hundreds of thousands of vaccinations due to its one shot use. The FDA and CDC after reviewing the cases recommended a pause out of an abundance of caution.
#MaltaDaily